Patents Assigned to The University of Melbourne of Royal Parade
  • Publication number: 20120046255
    Abstract: The present invention relates to non-steroidal compounds useful in the treatment of inflammatory conditions and pharmaceutical compositions comprising them.
    Type: Application
    Filed: April 14, 2008
    Publication date: February 23, 2012
    Applicant: THE UNIVERSITY OF MELBOURNE of ROYAL PARADE PARKVILLE
    Inventors: Alastair Stewart, Martin Banwell, Brenda Leung, Anu Augustine, Jacki Kitching, Tomasz Bilski
  • Patent number: 6723695
    Abstract: The present invention provides cytotoxic Epstein-Barr virus (EBV) T-cell epitopes derived from EBV structural antigens. Preferred epitopes include YLLEMLWRL (SEQ ID NO:1), YFLEILWGL (SEQ ID NO:32), YLLEILWRL (SEQ ID NO:33), YLQQNWWTL (SEQ ID NO:6), LLLALLFWL (SEQ ID NO:2), LLVDLLWLL (SEQ ID NO:3), LLLIALWNL (SEQ ID NO:4), WLLLFLAIL (SEQ ID NO:5), TLLVDLLWL (SEQ ID NO:7), LLWLLLFLA (SEQ ID NO:8), ILLIIALYL (SEQ ID NO:9), VLFIFGCLL (SEQ ID NO:10), RLGATIWQL (SEQ ID NO:11), ILYFIAFAL (SEQ ID NO:15), SLVIVTTFV (SEQ ID NO:17), LMIIPLINV (SEQ ID NO:20), TLFIGSHVV (SEQ ID NO:24), LIPETVPYI (SEQ ID NO:26), VLQWASLAV (SEQ ID NO:27) and QLTPHTKAV (SEQ ID NO:29). The present invention also provides methods of treating or preventing EBV infection in subjects which involve administration of EBV cytotoxic T-cell epitopes.
    Type: Grant
    Filed: May 30, 2000
    Date of Patent: April 20, 2004
    Assignees: Council of the Queensland Institute of Medical Research, Commonwealth Scientific and Industrial Research Organisation of Limestone Avenue, The University of Melbourne of Royal Parade, Walter and Elisa Hall Institute of Medical Research of Royal Melbourne Hospital, CSL Limited
    Inventors: Scott Renton Burrows, Rajiv Khanna, Martina Alison Sherritt